[Phase I study of interferon-beta (MR-21) in patients with malignant tumors. The Cooperative Study Group of (MR-21) in Tumor].
D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009369:Neoplasms / Q000097:blood / Q000628:therapy*
D007370:Interferon Type I